La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Cencora Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Cencora ha un patrimonio netto totale di $1.1B e un debito totale di $4.7B, che porta il suo rapporto debito/patrimonio netto a 446.1%. Le sue attività totali e le sue passività totali sono rispettivamente $66.8B e $65.7B. L'EBIT di Cencora è $2.9B rendendo il suo rapporto di copertura degli interessi 14.8. Ha liquidità e investimenti a breve termine pari a $3.3B.

Informazioni chiave

446.1%

Rapporto debito/patrimonio netto

US$4.73b

Debito

Indice di copertura degli interessi	14.8x
Contanti	US$3.31b
Patrimonio netto	US$1.06b
Totale passività	US$65.71b
Totale attività	US$66.77b

Aggiornamenti recenti sulla salute finanziaria

Recent updates

Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings

Jul 16

Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning

Jun 30

Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?

Jun 28

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Jun 09

Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

May 21

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Apr 05

Cencora Remains Chronically Undervalued, With Material Growth Potential

Mar 25

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Mar 18

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Feb 25

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Feb 07

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Jan 05

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Jan 04

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Dec 15

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Nov 05

Is Cencora (NYSE:COR) A Risky Investment?

Nov 03

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Oct 18

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

Aug 01

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Jul 28

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Jun 19

Is AmerisourceBergen Corporation (NYSE:ABC) Trading At A 28% Discount?

May 01

Here's Why We Think AmerisourceBergen (NYSE:ABC) Is Well Worth Watching

Apr 10

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

Mar 02

AmerisourceBergen declares $0.485 dividend

Feb 01

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 25% Below Their Intrinsic Value Estimate

Jan 28

AmerisourceBergen partners with pharmaceutical company Civica

Jan 23

AmerisourceBergen: What Does The Valuation Look Like After The Recent Price Rise?

Jan 13

Does AmerisourceBergen (NYSE:ABC) Deserve A Spot On Your Watchlist?

Jan 10

AmerisourceBergen sued by DoJ over suspicious opioid orders

Dec 29

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( { COR di $47.3B ) non coprono le sue passività a breve termine ( $53.0B ).

Passività a lungo termine: Le attività a breve termine di COR ( $47.3B ) superano le sue passività a lungo termine ( $12.7B ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: Il rapporto debito netto/patrimonio netto ( 134.4% ) di COR è considerato alto.

Riduzione del debito: Il rapporto debito/patrimonio netto di COR è aumentato da 145% a 446.1% negli ultimi 5 anni.

Copertura del debito: Il debito di COR è ben coperto dal flusso di cassa operativo ( 91.1% ).

Copertura degli interessi: I pagamenti degli interessi sul debito di COR sono ben coperti dall'EBIT ( 14.8 x copertura).

Cencora Salute del bilancio

Salute finanziaria criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Is Cencora (NYSE:COR) A Risky Investment?

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

AmerisourceBergen (NYSE:ABC) Has A Pretty Healthy Balance Sheet

Recent updates

Chairman notifies of intention to sell stock

Cencora, Inc. Elects Frank Clyburn as New Independent Director, Effective October 1, 2024

Third quarter dividend of US$0.51 announced

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Cencora, Inc. Declares Quarterly Cash Dividend, Payable on August 26, 2024

Chairman notifies of intention to sell stock

Market Participants Recognise Cencora, Inc.'s (NYSE:COR) Earnings

Cencora, Inc. to Report Q3, 2024 Results on Jul 31, 2024

Cencora: Potential Exists, But Ambiguous Valuations And Data Breach Risks Are Concerning

Are Investors Undervaluing Cencora, Inc. (NYSE:COR) By 43%?

Chairman notifies of intention to sell stock

Here's Why Cencora (NYSE:COR) Can Manage Its Debt Responsibly

Insider exercised options and sold US$3.5m worth of stock

Chairman exercised options and sold US$1.4m worth of stock

Do Cencora's (NYSE:COR) Earnings Warrant Your Attention?

Second quarter dividend of US$0.51 announced

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on May 24, 2024

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Cencora, Inc. (NYSE:COR) announces an Equity Buyback for $2,000 million worth of its shares.

Executive VP & COO exercised options and sold US$4.9m worth of stock

Cencora, Inc. to Report Q2, 2024 Results on May 01, 2024

Investors Interested In Cencora, Inc.'s (NYSE:COR) Earnings

Cencora Remains Chronically Undervalued, With Material Growth Potential

Chairman exercised options and sold US$1.6m worth of stock

Cencora, Inc.'s (NYSE:COR) Intrinsic Value Is Potentially 53% Above Its Share Price

Cencora, Inc. Reaffirms Guidance for Year 2024

Cencora, Inc. Announces CEO Changes, Effective October 1, 2024

Cencora (NYSE:COR) Seems To Use Debt Quite Sensibly

Cencora’s FormularyDecisions Launches Payer Resource for Cell and Gene Therapy Products

Cencora (NYSE:COR) Is Posting Promising Earnings But The Good News Doesn’t Stop There

First quarter dividend of US$0.51 announced

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Price target increased by 9.0% to US$235

Consensus EPS estimates fall by 14%

Cencora, Inc. Declares Quarterly Cash Dividend on Common Share, Payable on February 26, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc., Annual General Meeting, Mar 12, 2024

Cencora, Inc. to Report Q1, 2024 Results on Jan 31, 2024

Cencora, Inc.'s (NYSE:COR) Business Is Yet to Catch Up With Its Share Price

Cencora: Continued Economic Value On The Table Across All Investment Horizons

Chairman recently sold US$8.7m worth of stock

A Look At The Fair Value Of Cencora, Inc. (NYSE:COR)

Chairman exercised options and sold US$3.1m worth of stock

Insider recently sold US$2.0m worth of stock

Executive VP & CFO exercised options and sold US$3.1m worth of stock

Cencora (NYSE:COR) Is Paying Out A Larger Dividend Than Last Year

Cencora, Inc. Declares Quarterly Dividend, Payable November 27, 2023

Is Cencora (NYSE:COR) A Risky Investment?

Full year 2023 earnings: EPS misses analyst expectations

Cencora: New Name, Same Old Economic Leverage, Reiterate Buy

Chairman exercised options and sold US$2.7m worth of stock

Cencora, Inc. to Report Q4, 2023 Results on Nov 02, 2023

Insider exercised options and sold US$2.0m worth of stock

Now 20% undervalued after recent price drop

Chairman exercised options and sold US$1.0m worth of stock

Now 21% undervalued

Amerisourcebergen Corporation Elects Werner Baumann and Lauren Tyler to Its Board of Directors

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation Declares Quarterly Cash Dividend, Payable on August 28, 2023

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

AmerisourceBergen Corporation (NYSE:ABC) Shares Could Be 34% Below Their Intrinsic Value Estimate

AmerisourceBergen: Great Company, Wrong Price (Rating Downgrade)

Chairman notifies of intention to sell stock

AmerisourceBergen Corporation to Report Q3, 2023 Results on Aug 02, 2023

Insider exercised options and sold US$3.0m worth of stock

We Think AmerisourceBergen (NYSE:ABC) Can Stay On Top Of Its Debt

Chairman exercised options and sold US$1.1m worth of stock

TPG Inc. (NasdaqGS:TPG), AmerisourceBergen Corporation (NYSE:ABC) and the management team of OneOncology, Inc. acquired OneOncology, LLC from General Atlantic Service Company, L.P. and others.

Executive VP & Chief Legal Officer recently sold US$731k worth of stock

Chairman exercised options and sold US$966k worth of stock